Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study

Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study

Show other versions (1)

Background and Objective: To assess whether methylcobalamin and alpha lipoic acid (ALA) added to pregabalin provide additional benefit compared to pregabalin alone in type 2 diabetes mellitus associated peripheral neuropathy. Setting and Design: An open label, randomized, controlled parallel-group p...

Full description

Bibliographic Details
Main Authors: D Vasudevan, Manoj M Naik, Qayum I Mukaddam
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
Alpha lipoic acid (ALA)
diabetic neuropathy
methylcobalamin
pregabalin
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2014;volume=17;issue=1;spage=19;epage=24;aulast=Vasudevan

Internet

http://www.annalsofian.org/article.asp?issn=0972-2327;year=2014;volume=17;issue=1;spage=19;epage=24;aulast=Vasudevan

Similar Items